+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-08-19Number of Pages: 72

Intrathecal Pumps Market (Pain and Spasticity Management, Payer Breakdown for Reimbursement and Drugs in Intrathecal Pumps) - Global Industry Analysis, Size, Share, Procedures, Growth, Trends and Forecast, 2014 - 2020

Intrathecal pump is a surgically implanted system used to infuse potent medication directly into or around the spinal cord. These pumps are typically intended for use in chronic pain and spasticity management for delivering potent medicines in the intrathecal space which allows administration of drugs in very low doses. This significantly reduces the side effects associated with the drugs. The global intrathecal pumps market was valued at USD 199.8 million in 2013, and is expected to grow at a CAGR of 4.1% to reach an estimated value of 264.8 million by 2020.
 
The global intrathecal pumps market is witnessing healthy growth amidst the frequent product recalls. Driving factor for the market growth is the device’s ability to reduce debilitating pain and drug administration in low doses. This benefits patients with lesser side effects and more rapid therapeutic effects compared to other forms of medication. Chronic pain affecting approximately 20% to 30% of the U.S. population is the largest driver for intrathecal pumps. The prevalence of chronic pain is also severe in other parts of the world. In 2013, the market for these pumps was largely driven by demand for treating chronic pain and this application alone contributed to more than two-third of the total market revenue. The pain management application is expected to maintain its top position during the forecast period from 2014 to 2020 due to large untapped patient base and wider side effects of existing opioid analgesics administered via routes other than intrathecal.
 
Geographically, the global intrathecal pumps market is segmented into four major regions, namely, North America, Europe, Asia-Pacific and Rest of the World. In 2013, North America was the largest market for intrathecal pumps followed by Europe and accounted for more than half of the revenue share in the market. This geography is expected to register a growth at a CAGR close to 4% during the forecast period. The improving healthcare infrastructure in Asia-Pacific region, particularly in China and India, large patient base with chronic pain and improving economies are propelling the growth of intrathecal pumps market in this region.
 
The global intrathecal pumps market is governed by very few players such as Medtronic, Inc., Flowonix Medical, Codman & Shurtleff, Inc. (a Johnson & Johnson company), and Tricumed Medizintechnik GmbH. Though several product recalls by leading companies in the market have hampered the market growth to some extent, many new companies are trying to enter the market to explore the untapped opportunities in the future.
 
 

 
The report on intrathecal pumps market analyzes the current as well as future prospects and various facets of the market in detail. Intrathecal infusion pumps are used to deliver therapeutic doses of drugs for pain and spasticity, into a patient’s body, particular in the spine at a precisely controlled rate. The global intrathecal pumps market has witnessed significant growth in the past due to worldwide increase in number of patients with chronic pain and cancer pain. This report provides an in-depth and comprehensive analysis of the global intrathecal pumps market. The research covers current as well as future prospects of the market globally. It includes an exhaustive executive summary, which covers a market snapshot that provides information of various segments such as applications (pain and spasticity) and geography (North America, Europe, Asia-Pacific and Rest of the World).
 
For the research on this topic, we conducted in-depth interviews and discussions with a wide range of key opinion leaders within intrathecal pumps market, which was supplemented by extensive secondary research. The market assessment and forecast in terms of revenue (USD million) and number of procedures for each segment of intrathecal pumps market have been provided for the period 2012 to 2020, considering 2013 as the base year. The report also provides the compounded annual growth rate (CAGR %) for the global intrathecal pumps market and each sub-segment, for the forecast period 2014 to 2020. Growth rates for each segment within the global intrathecal pumps market have been determined after thorough analysis of past trends, demographics, future trends, technological developments, regulatory requirements.
 
The intrathecal pumps market is segmented based on major applications into two categories: pain and spasticity management. The market for these applications has been extensively analyzed based on the safety, and efficacy of the procedure, and sales revenue of the devices as well as geographic presence. According to our estimates, in 2013, the pain management application accounted for largest share in the global intrathecal pumps market and is expected to grow more in the near future. Each application of intrathecal pumps has been further segmented into four major geographies: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The report also includes the market size and forecast for the U.S. and Canada in North America. 
 
Along with the overall intrathecal pumps market, the report also studies the market size and forecast for each segment with respect to all four regions, for the period 2012 to 2020 along with the CAGR (%) for the forecast period 2014 to 2020. The research study also incorporates the competitive scenario in these regions. The study also includes qualitative analysis of the competitive scenario and governmental regulations in these regions. In the market overview section of the report on intrathecal pumps market, a detailed qualitative analysis of the major market dynamics such as drivers, restraints and opportunities, along with Porter’s five forces analysis and market share analysis of drugs administered intrathecally have been discussed. This section of the report also market share analysis in 2013 for the major drugs used for intrathecal administration to treat pain and spasticity.
 
The study also suggests a list of recommendations that is likely to help service providers in decision making process, establish a strong presence and increase market share in the market. These recommendations are based on the observed trends and dynamics of the intrathecal pumps market. The report also profiles major players in the intrathecal pumps market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players covered in this report are Medtronic, Inc., Codman & Shurtleff, Inc., Flowonix, Inc., Arrow International, Inc. and Tricumed GmbH.
 
The global intrathecal pumps market is segmented as follows:
 
Intrathecal Pumps Market, by Application
  • Pain Management
    • North America
      • U.S.
      • Canada
    • Europe
    • Asia Pacific
    • Rest of the World
  • Spasticity Management
    • North America
      • U.S.
      • Canada
    • Europe
    • Asia Pacific
    • Rest of the World


 
 
Back To Top